Cognition Therapeutics Inc (CGTX) Stock Could Soon Reward Patient Investors

Cognition Therapeutics Inc (NASDAQ: CGTX) is -66.75% lower on its value in year-to-date trading and has touched a low of $0.22 and a high of $2.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGTX stock was last observed hovering at around $0.58 in the last trading session, with the day’s gains setting it 0.01%.

Currently trading at $0.59, the stock is 75.92% and 74.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.9 million and changing 1.68% at the moment leaves the stock 24.46% off its SMA200. CGTX registered -16.08% loss for a year compared to 6-month loss of -18.61%. The firm has a 50-day simple moving average (SMA 50) of $0.33706 and a 200-day simple moving average (SMA200) of $0.47286.

The stock witnessed a 102.86% gain in the last 1 month and extending the period to 3 months gives it a 66.15%, and is 89.96% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.34% over the week and 11.58% over the month.

Cognition Therapeutics Inc (CGTX) has around 28 employees, a market worth around $36.48M and $0.00M in sales. Distance from 52-week low is 164.73% and -76.79% from its 52-week high. The company has generated returns on investments over the last 12 months (-265.34%).

The EPS is expected to grow by 52.62% this year.

Cognition Therapeutics Inc (CGTX) Top Institutional Holders

53.0 institutions hold shares in Cognition Therapeutics Inc (CGTX), with institutional investors hold 18.94% of the company’s shares. The shares outstanding are 61.97M, and float is at 50.00M with Short Float at 3.08%. Institutions hold 18.79% of the Float.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.15 million shares valued at $1.9 million. The investor’s holdings represent 2.8644% of the CGTX Shares outstanding. As of 2024-06-30, the second largest holder is AWM INVESTMENT COMPANY, INC. with 0.65 million shares valued at $1.08 million to account for 1.6224 of the shares outstanding. The other top investors are ALYESKA INVESTMENT GROUP, L.P. which holds 0.5 million shares representing 1.248% and valued at over $0.83 million, while TIMELO INVESTMENT MANAGEMENT INC. holds 0.9021 of the shares totaling 0.36 million with a market value of $0.6 million.

Cognition Therapeutics Inc (CGTX) Insider Activity

The most recent transaction is an insider purchase by Ricciardi Lisa,the company’sCEO & President. SEC filings show that Ricciardi Lisa bought 38,851 shares of the company’s common stock on Jan 31 ’25 at a price of $0.77 per share for a total of $30001.0. Following the purchase, the insider now owns 38851.0 shares.

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.